...
首页> 外文期刊>Kidney International Reports >SUN-321 INVESTIGATING THE EFFECTIVENESS AND SAFETY OF A VERY LOW CALORIE DIET (VLCD) AS A METHOD OF WEIGHT LOSS IN PATIENTS RECEIVING HAEMODIALYSIS THERAPY
【24h】

SUN-321 INVESTIGATING THE EFFECTIVENESS AND SAFETY OF A VERY LOW CALORIE DIET (VLCD) AS A METHOD OF WEIGHT LOSS IN PATIENTS RECEIVING HAEMODIALYSIS THERAPY

机译:SUN-321研究一种非常低热量饮食(VLCD)的功效和安全性,作为接受血液透析疗法的患者的减肥方法

获取原文
           

摘要

Very Low Calorie Diets (VLCD) have been demonstratedto achieve rapid and significant weight loss in obese people withoutkidney disease. However, there is no published evidence on the use ofVLCD in end-stage kidney disease (ESKD) patients. Current manufac-turers’ guidelines state the meal replacement VLCD are contra-indicatedin patients with impaired kidney function (eGFR <60ml/min). The aimof the study is to determine if the use of a VLCD with 3 meal re-placements is safe and effective for weight loss in patients with ESKDtreated with haemodialysis (HD).
机译:事实证明,极低卡路里饮食(VLCD)可在没有肾脏疾病的肥胖人群中实现快速显着的体重减轻。但是,尚无已发表的证据表明在晚期肾病(ESKD)患者中使用VLCD。当前制造商的指南指出,对于肾脏功能受损(eGFR <60ml / min)的患者,禁食替代VLCD是禁忌的。这项研究的目的是确定使用带有3餐替代品的VLCD对经血液透析(HD)治疗的ESKD患者的减肥是否安全有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号